IPFA-PPTA joint Statement CHMP Position Paper on Quality and Safety Assessment for PMF Certification

10 March 2021

The International Plasma and Fractionation Association and the Plasma Protein Therapeutics Association are pleased with the recent publication by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP). Read the full statement here.